文献
J-GLOBAL ID:202002238608720669
整理番号:20A1205698
年齢は自家造血幹細胞移植を受けている多発性骨髄腫患者の全生存率に対する予後因子である【JST・京大機械翻訳】
Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation
著者 (20件):
Cordas dos Santos David M.
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Cordas dos Santos David M.
(Department of Medicine III, University Hospital, Ludwig-Maximilians-University, Munich, Germany)
,
Saliba Rima M.
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Patel Romil
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Bashir Qaiser
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Saini Neeraj
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Hosing Chitra
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Kebriaei Partow
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Khouri Issa F.
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Nieto Yago
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Popat Uday
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Ahmed Haris
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Lee Hans C.
(Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Manasanch Elisabet E.
(Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Patel Krina K.
(Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Thomas Sheeba K.
(Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Weber Donna M.
(Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Orlowski Robert Z.
(Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Champlin Richard E.
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Qazilbash Muzaffar H.
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas)
資料名:
Biology of Blood and Marrow Transplantation
(Biology of Blood and Marrow Transplantation)
巻:
26
号:
6
ページ:
1077-1083
発行年:
2020年
JST資料番号:
W1625A
ISSN:
1083-8791
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)